BioOrbit CEO on Developing Cancer Treatments in Zero Gravity
Share
Katie King, cofounder and CEO of BioOrbit, discussed the company's recent milestone in producing protein crystals in space. BioOrbit launched a record-breaking mission to the International Space Station, achieving the largest scale production of protein crystals in a microgravity environment by one to two orders of magnitude. King spoke to Bloomberg's Tom Mackenzie.
More from Australia
Woodside Energy outlines strategy targeting US$40B cash flow
News Corp posts US$2.28B first quarter revenue
REA Group Q1 revenue increases 11% to $450M
Light & Wonder Q3 net income lifts 17% to US$133M
National Australia Bank reports $6.14B in full-year profit
EY Australia launches new public interest council